Physician

Juan Antonio Astruc, M.D.

According to 2025 Medicare claims, Juan Astruc, M.D. (NPI: 1477515237) practices ophthalmology in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is VIRGINIA EYE CONSULTANTS INC (NPI: 1992727820; TIN: 541150779) and primary practice location at 23235-1989.

Astruc's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,757 traditional Medicare patients, billed 41,443 HCPCS/CPT codes, and received $5,741,893 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 513 prescription claims across 156 beneficiaries totaling $25,927 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $108. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $48,483 and ending at $25,927. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.9M$5.7M2015 Medicare payment: $3,849,307 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,163,232 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,716,904 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,112,234 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,377,983 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,357,521 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,249,598 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,752,914 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,691,507 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,741,893 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,40914,806$3,849,307
20161,43514,697$4,163,232
20171,46615,752$4,716,904
20181,62217,148$5,112,234
20191,63718,037$5,377,983
20201,45217,226$5,357,521
20211,46516,533$5,249,598
20221,53015,385$4,752,914
20231,66923,243$4,691,507
20241,75741,443$5,741,893

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$88K$177K2015 Drug cost: $48,483 (USD; Tot_Drug_Cst)2016 Drug cost: $40,416 (USD; Tot_Drug_Cst)2017 Drug cost: $35,068 (USD; Tot_Drug_Cst)2018 Drug cost: $39,692 (USD; Tot_Drug_Cst)2019 Drug cost: $176,687 (USD; Tot_Drug_Cst)2020 Drug cost: $27,960 (USD; Tot_Drug_Cst)2021 Drug cost: $29,286 (USD; Tot_Drug_Cst)2022 Drug cost: $37,834 (USD; Tot_Drug_Cst)2023 Drug cost: $47,257 (USD; Tot_Drug_Cst)2024 Drug cost: $25,927 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015192719$48,483
2016181602$40,416
2017160490$35,068
2018171581$39,692
2019165561$176,687
2020146468$27,960
2021141461$29,286
2022136452$37,834
2023150468$47,257
2024156513$25,927

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg4563,342$661
67028Injection of drug into eye6062,608$98
92014Established patient complete exam of visual system1,0411,385$89
92134Imaging of retina9193,030$30
92250Photography of the retina1,0371,242$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1415,837$5,453
Bromfenac SodiumBromfenac Sodium11252$1,572
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat514,012$1,007
LatanoprostLatanoprost1166,148$811
OfloxacinOfloxacin561,359$640

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$108Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Juan Antonio Astruc, M.D.?

Tedicare shows public-source Medicare data for Juan Antonio Astruc, M.D. (NPI 1477515237), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Juan Antonio Astruc, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Juan Antonio Astruc, M.D.?

Juan Antonio Astruc, M.D. is linked to VIRGINIA EYE CONSULTANTS INC (billing NPI 1992727820) in the available physician profile data.

Does Juan Antonio Astruc, M.D. have Open Payments data?

Juan Antonio Astruc, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.